|
|
||||||||
[3H]BUMETANIDE BINDING AND INHIBITION OF Na+ + K+ + Cl- CO-TRANSPORT: DEMONSTRATION OF SPECIFICITY BY THE USE OF MDCK CELLS DEFICIENT IN CO-TRANSPORT ACTIVITY
1 Department of Pathophysiology, Karol Marcinkowski's University Medical School, Poznan, Poland
2 Department of Physiological Sciences, The Medical School, Framlington Place, The University of Newcastle upon Tyne, Newcastle upon Tyne NE2 4HH
Cultured renal MDCK cells possess a Na+ + K+ + Cl- co-transport system which is inhibited with high affinity by loop diuretics (K0·5 for bumetanide inhibition = 0·28 µM). By the use of mutant cell lines deficient in co-transport flux the specific interaction of [3H]bumetanide with the co-transporter has been identified. [3H]Bumetanide uptake in parental MDCK-N cells in the range 0-1 µM comprises a non-saturable linear component, assessed by the inclusion of 100 µM-unlabelled bumetanide and a saturable component (K0·5 = 0·19 µM and Bmax = 0·55 pmol/106 cells). Though the magnitude of the linear non-specific component was little diffe; ent between the parental MDCK-N cell line and two co-transport-deficient mutant cell lines (LKC1 and LKA3), the magnitude of the saturable component was markedly reduced in both co-transport-deficient mutants. In addition to the saturable component associated with flux inhibition a lower-affinity uptake displaceable by excess unlabelled bumetanide was evident in MDCK-N cells comprising 8 pmol/106 cells measured at 10 µM-[3H]bumetanide. This lower- affinity uptake was present in both co-transport-deficient mutant cell lines confirming its lack of association with inhibition of co-transport flux. In MDCK cells possessing the co- transporter, an estimate of the turnover number was made when co-transport flux and specific bumetanide uptake at 0·5 µM-[3H]bumetanide were measured in the same cell batch. At 37 °C this was 113 K+ ions site-1 s-1.
Submitted on August 3, 1987
This article has been cited by other articles:
![]() |
S. S. Shankar and D. C. Brater Loop diuretics: from the Na-K-2Cl transporter to clinical use Am J Physiol Renal Physiol, January 1, 2003; 284(1): F11 - F21. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |